Additional Proxy Soliciting Materials (definitive) (defa14a)
15 September 2020 - 7:20AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a)
of the
Securities Exchange Act of 1934
(Amendment No. 3)
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
|
☐
|
Preliminary Proxy Statement
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☐
|
Definitive Proxy Statement
|
☒
|
Definitive Additional Materials
|
☐
|
Soliciting Material Pursuant to Rule §240.14a-12
|
Zomedica
Pharmaceuticals Corp.
(Name of Registrant as Specified In Its
Charter)
(Name of Person(s) Filing Proxy Statement,
if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate
box):
|
☒
|
No fee required.
|
|
☐
|
Fee computed on table below per Exchange
Act Rules 14a-6(i)(4) and 0-11.
|
|
|
(1)
|
Title of each class of securities to which
transaction applies:
|
|
|
(2)
|
Aggregate number of securities to which
transaction applies:
|
|
|
(3)
|
Per unit price or other underlying value
of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state
how it was determined):
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
Total fee paid:
|
|
☐
|
Fee paid previously with preliminary materials.
|
|
☐
|
Check box if any part of the fee is offset
as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify
the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
(2)
|
Form, Schedule or Registration Statement
No.:
|
|
|
(3)
|
Filing Party:
|
|
|
(4)
|
Date Filed:
|
On September 14,
2020, Alliance Advisors, the proxy solicitor for Zomedica Pharmaceuticals Corp. (the “Company”) mailed the
following letter to selected shareholders of the Company (the
“Shareholders Letter”) in advance of the Company’s annual and special virtual-only meeting of shareholders,
scheduled to be held on Friday, September 25, 2020. The Company issued a press release on September 14, 2020 containing the Shareholders Letter. A copy of
the press release containing Shareholders Letter is available on the Company’s website at www.zomedica.com.
September 14, 2020
Dear Zomedica Pharmaceuticals
Corp. Shareholder:
Our records
reflect that you have not yet voted your shares with respect to Proposal 3 to be acted upon at the Annual and Special
Virtual-Only Meeting of Zomedica Pharmaceuticals Corp. to be held on Friday, September 25, 2020 at 8:30 a.m., Eastern time,
pursuant to which shareholders are being asked to approve a reverse stock split, or consolidation, of our common shares at a
ratio between one-for-25 and one-for-50.
The reverse stock split
is intended to increase the per share trading price of our common shares in order to maintain the listing of the common shares
on the NYSE American exchange. The board believes that it is in the best interest of shareholders to effect a reverse split to
maintain our NYSE American listing. Additionally, increasing the trading price of our common shares could increase the interest
of institutional and other investors in our common shares and may expand the pool of investors that may consider investing in our
company. If we are unable to maintain our NYSE American listing, our common shares would cease to trade on the NYSE American and
would trade in the over-the-counter market on either the OTC Bulletin Board or the “pink sheets” maintained by the
National Quotation Bureau. We believe the loss of our NYSE American listing would significantly impact the liquidity of your common
shares and could negatively affect the trading price of your common shares. As a result, the board recommends that you vote your
shares FOR Proposal 3.
Please note that the
reverse stock split will affect all of our shareholders uniformly and will not affect any shareholder’s percentage ownership
interest or proportionate voting power, except for minor adjustment due to fractional shares.
Please vote your shares
today by calling (833) 670 – 0700 Monday through Friday, 9:00 a.m. to 10:00 p.m. Eastern Time.
Alternatively, if you
wish you can email me your voting instructions at mcarlson@allianceadvisors.com.
Sincerely,
Melissa Carlson
Vice President
Zomedica (AMEX:ZOM)
Historical Stock Chart
From Apr 2024 to May 2024
Zomedica (AMEX:ZOM)
Historical Stock Chart
From May 2023 to May 2024